Healthcare stocks were lower today with the NYSE Healthcare
Sector Index falling about 0.1% and shares of healthcare companies
in the S&P 500 also were down 0.1% as a group.
In company news, shares of Biota Pharmaceuticals Inc. (
) were up more than 10% Friday afternoon after the drugmaker's
chief executive this week added to his personal stake in the maker
of anti-bacterial and anti-viral products.
Russel Plumb acquired a total of 32,031 BOTA shares in a short
string of open-market purchases on Tuesday and Wednesday, paying a
combined $95,692, or about $2.99 a share, according to a new
regulatory filing. The deals boost his overall stake to 127,579
BOTA shares recently were ahead 12.5% at $3.43 apiece, or 4
cents under its session high. The stock has a 52-week range of
$2.35 to $7.07 a share, slipping about 3.5% over the past 12
In other sector news,
(+) NKTR, (+13.5%) FDA advisory panel recommends against
requiring cardiovascular outcomes trials for peripherally-acting
mu-opioid receptor antagonist drugs, including the company's
Movantiktm drug candidate for opoid-induced constipation.
(-) OMED, (-14.9%) Voluntarily halts patient enrollment and
dosing in Phase 1 testing of vantictumab and Fzd8-Fc, its
prospective monoclonal antibody cancer treatments.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.